Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure.
about
Impact of HIV/AIDS on care and outcomes of severe sepsis.Extra Corporeal Membrane Oxygenation (ECMO) in three HIV-positive patients with acute respiratory distress syndromeOne-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute respiratory failure.Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia.Can health care costs be reduced by limiting intensive care at the end of life?Marginally effective medical care: ethical analysis of issues in cardiopulmonary resuscitation (CPR)Primary care delivery is associated with greater physician experience and improved survival among persons with AIDS.Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy.Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapyOutcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.A view from the front lines of bioethics.Low tidal volume ventilation is associated with reduced mortality in HIV-infected patients with acute lung injury.A history of ethics and law in the intensive care unit.Survival for patients With HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy.Intensive Care Usage by HIV-Positive Patients in the HAART EraEtiology and outcomes for patients infected with HIV in intensive care units in a tertiary care hospital in China.Extracorporeal membrane oxygenation as treatment for acute respiratory failure and subsequent pneumothorax caused by Pneumocystis jirovecii pneumonia in a kidney transplant recipient.Outcomes of HIV-associated pneumocystis pneumonia at a South African referral hospital
P2860
Q25255282-3EA5346A-6F85-4CAB-999B-7D9E71764ACEQ33755302-2D3A5FB2-72B2-45E7-9E33-274CED7942B2Q33919235-1AFF8C7D-279A-43B2-A8A0-302769E2780CQ33996551-429FA27D-47ED-4D39-8F4B-FA1D823FEF69Q34118843-8A6D5405-3ACF-4962-9D70-AEABDE77A4F7Q34387928-C9F306EE-57FD-40F2-84C9-C0C6DFC7D0CAQ34741100-43B591D7-DBD7-4901-BF4F-3B1E259C904BQ34770074-2AFB53DC-657C-49AC-87C0-863D22CD603CQ36184151-9B306B76-3D6D-486C-BA7D-CC42F80F816CQ36310358-28CD2F45-0B5E-4F6F-8ED7-D14559CE0A84Q36607829-1668D56E-A4F7-437F-AA57-B23C7E96D011Q37179389-198D46AF-C8E4-45B6-AC8C-E9A31BF194A6Q37186431-CA48D9E7-1164-4E9A-9471-498DE5D3FCCFQ37342714-48AA945B-CBA5-488C-B017-D7B406BE129FQ38897247-0C1301FA-D3C6-41FD-9C80-E86D77091115Q42200462-B3D50F76-8131-4332-8D20-9EF7C1B24EF0Q44381675-44F2498A-14D0-4FF0-BD05-D5838C4BBF73Q56956015-110DA69E-6EFB-4493-8F8E-6FBBA128D4A8
P2860
Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Cost and outcome of intensive ...... nd severe respiratory failure.
@en
Cost and outcome of intensive ...... nd severe respiratory failure.
@nl
type
label
Cost and outcome of intensive ...... nd severe respiratory failure.
@en
Cost and outcome of intensive ...... nd severe respiratory failure.
@nl
prefLabel
Cost and outcome of intensive ...... nd severe respiratory failure.
@en
Cost and outcome of intensive ...... nd severe respiratory failure.
@nl
P2093
P1476
Cost and outcome of intensive ...... nd severe respiratory failure.
@en
P2093
A A Scitovsky
D C Berrios
E Charlebois
R M Wachter
P304
P356
10.1001/JAMA.1995.03520270064033
P407
P577
1995-01-01T00:00:00Z